PRODUCT DETAIL

Voriconazole Fresenius Kabi 200 mg prášok na infúzny roztok

Code

7235B

MA number

26/0513/15-S

Product Form:

plv ifo 20x200 mg (liek.inj.skl.)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

MAH, country:

Fresenius Kabi s.r.o., Czechia

Therapeutic Class:

26 - ANTIMYCOTICA (LOKÁLNE A CELKOVÉ)

ATC:

J	ANTIINFECTIVES FOR SYSTEMIC USE
J02	ANTIMYCOTICS FOR SYSTEMIC USE
J02A	ANTIMYCOTICS FOR SYSTEMIC USE
J02AC	Triazole and tetrazole derivatives
J02AC03	Voriconazole

Shelf life:

Container:

glass vial

Route of admin.:

Intravenous use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	21.12.2015
Pediatric indication:	Yes
Pediatric posology:	Yes
Pediatric warnings:	Yes
PIL:	PIL_Voriconazole Fresenius Kabi 200 mg plv ifo_05.2024.pdf
SPC:	SPC_Voriconazole Fresenius Kabi 200 mg plv ifo_05.2024.pdf
Safety feature	Yes
Data update:	19.05.2020